Toxic epidermal necrolysis (TEN, Lyell syndrome) is the most severe form of the SJS/TEN spectrum, a T-cell-mediated drug reaction characterized by widespread keratinocyte apoptosis and full-thickness epidermal necrosis. With >30% BSA involvement (this patient has 45%), mortality ranges from 25–50%. The pathogenesis involves drug-specific HLA-restricted CD8+ cytotoxic T-lymphocyte responses releasing granulysin, perforin/granzyme, and TNF-α. The SINGLE MOST CRITICAL intervention is IMMEDIATE WITHDRAWAL of the offending drug (carbamazepine in this case, which is a high-risk agent with HLA-B*15:02 association in Indian populations). Transfer to a burn ICU or specialized ICU is mandatory for fluid/electrolyte resuscitation, temperature regulation, wound care with non-adherent dressings, pain control, and nutritional support. SCORTEN scoring within 24 hours stratifies mortality risk (each point increases mortality; ≥5 points = >90% mortality). Cyclosporine 3–5 mg/kg/day has the strongest evidence from the RegiSCAR cohort for adjunctive immunomodulation (Sekula P et al. JID 2013). Systemic steroids are controversial and may increase mortality if prolonged. The anchor fact is that drug withdrawal is the most important intervention and must occur immediately alongside ICU-level supportive care.
Sekula P et al. JID 2013 (RegiSCAR); Harrison's 21st ed
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.